Nutlin‐3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation
Abstract Adrenocortical carcinoma (ACC) is a rare malignancy, and CTNNB1 is frequently mutated in ACC. Our study aims to screen for effective agents with antineoplastic activity against ACC with CTNNB1 mutation. In‐silico screening of the Genomics of Drug Sensitivity in Cancer (GDSC) database was co...
Furkejuvvon:
| Váldodahkkit: | , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Wiley
2018-04-01
|
| Ráidu: | Cancer Medicine |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1002/cam4.1431 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|